Europharma Research & Science Centersp. z o.o.
Research and experimental development in natural sciences and engineering
Overview
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 3 of 6 financial statements were filed late (the longest delay 205 days for 2024).
- 2025not filed
- 202405/02/2026
- 202305/08/2024
- 202215/07/2023
- 202104/01/2023
- 202015/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.
Results vs industry
Industry
Authorized Representatives
Manner of representation
In the case of a multi-member management board, the company may be represented by the President of the Management Board and the Vice-President of the Management Board, each of them independently; however, in the event of the appointment of a member of the management board and/or a commercial proxy, the company may be represented by the President of the Management Board and the Vice-President of the Management Board, each of them independently, or by two members of the management board acting jointly, or by a member of the management board acting jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 255 | $6,888.17 | 51% | |
Lars Almgren-Rachtan | 245 | $6,618.04 | 49% |
Agnieszka Almgren Rachtan and Lars Almgren Rachtan hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2007-02-24.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
6 public aid cases recorded, with a total value of $317,213.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 26, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $3,838$3,838 | Prezydent Miasta Katowice | |
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $2,924$2,924 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $2,284$2,284 | Prezes Zakładu Ubezpieczeń Społecznych |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Sieć Badawcza Łukasiewicz – Instytut Sztucznej Inteligencji I CyberbezpieczeństwaResearch institute | $6,514,456.26 | ai.lukasiewicz.gov.pl | ||
| SR Roboticssp. z o.o. | $4,456,035.13 | srrobotics.pl | ||
| ProgresjaS.A. | $1,461,322.62 | progresja.co | ||
| Clinical Medical Researchsp. z o.o. | $1,047,450.44 | clinicalmedicalresearch.pl | ||
| Specjalistyczne Techniki Izolacyjnesp. z o.o. | $838,388.03 | sti-izolacje.pl | ||
| Clinic Bbpsp. z o.o. | $0.00 | clinicbbp.com | ||
| Kopiltechsp. z o.o. | – | kopiltech.pl | ||
| Blancsp. z o.o. | – | blanc.pl | ||
| Eko-Precyzjasp. z o.o. | – | eko-precyzja.pl | ||
| Adapt-Esp. z o.o. | – | adapt-e.com |
Change history
| Date | Event | |
|---|---|---|
| 2023-12-21 | PKD change (Removed: 73.20.Z; Added: 72.11.Z) | |
| 2023-02-14 | Name change (Europharma M.rachtan → Europharma Research & Science Center) | |
| 2019-12-06 | PKD change (Removed: 14 codes) | |
| 2011-08-17 | Address change (Chorzowska 50, 40-121, Katowice → Krzywa 6, 40-061, Katowice) | |
| 2008-05-30 | Switch to PKD 2007 (15 PKD 2004 codes → 23 PKD 2007 codes) |
FAQ
Last updated: 2026-04-14